Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Aruny

Vascular & Interventional Radiology New Haven, CT Medical Doctor

NPI 1568452969 CMS profile 207144

20 York St, Ynhh South Pavilion - 2Nd Floor, New Haven, CT 06510

Open in the dashboard

General payments

$71,857

287 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$105,695 paid to institutions, not to them · program years 2021–2025

Through program year 2025, John Aruny of New Haven, CT is reported in the CMS Open Payments database as having received $71,857 across 287 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $105,695 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $264 7
2024 General $10,276 31
2023 General $6,454 42
2022 General $15,106 55
2021 General $3,696 36
2020 General $13,018 20
2019 General $23,043 96

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Aruny
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to John Aruny were reported at $264. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year John Aruny Vascular & Interventional Radiology median Middle half National median
2019 $23,043 $422 $125–$1,555 $163
2020 $13,018 $200 $68–$652 $114
2021 $3,696 $280 $99–$866 $132
2022 $15,106 $433 $137–$1,497 $149
2023 $6,454 $506 $152–$2,019 $160
2024 $10,276 $556 $175–$1,930 $164
2025 $264 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $33,812 88 payments
  2. Boston Scientific Corporation $19,291 70 payments
  3. Bard Peripheral Vascular, Inc. $5,641 34 payments
  4. VentureMed Group, Inc. $5,364 27 payments
  5. Medtronic, Inc. $1,656 4 payments
  6. Inari Medical, Inc. $1,090 3 payments
  7. Philips Electronics North America Corporation $731 6 payments
  8. Medtronic Vascular, Inc. $579 5 payments
  9. LeMaitre Vascular, Inc. $542 11 payments
  10. AngioDynamics, Inc. $449 3 payments
  11. Other $2,703 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $41,850 18 payments
  2. Food and Beverage $16,916 243 payments
  3. Travel and Lodging $6,992 22 payments
  4. Honoraria $6,100 4 payments
Products named General payments · program years 2019–2025
  1. VIABAHN Endoprosthesis $14,446 22 payments
  2. GORE VIABAHN Endoprosthesis $8,784 21 payments
  3. FLEX Vessel Prep System $5,156 26 payments
  4. General - Therapies $4,981 7 payments
  5. GENERAL VASCULAR INTERVENTION $3,687 8 payments
  6. WAVELINQ $2,900 1 payment
  7. GENERAL - VASCULAR INTERVENTION $2,767 3 payments
  8. ACUSEAL Vascular Graft $2,376 6 payments
  9. VIATORR Endoprosthesis $2,250 2 payments
  10. GENERAL THERAPIES $1,961 6 payments
  11. Other $18,729 152 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 105 billing codes

Paid by Medicare

$58,161

Of which drugs: $151

Medicare patients

299

Average age 65

Services billed

2,143

144 women, 155 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 73%
Diabetes 58%
Heart failure 42%
Arthritis 42%
Ischemic heart disease 38%
Depression 30%
Atrial fibrillation 27%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 12 1,300 $135

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

287 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record